Erectile dysfunction in the elderly man

Urologia Internationalis

Volumn 70, Issue 2, 2003, Pages 89-99

  Hauri, D ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRIC OXIDE; SILDENAFIL;

AGED; ARTERIOSCLEROSIS; CASTRATION; CORPUS CAVERNOSUM; DIABETES MELLITUS; ERECTILE DYSFUNCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMPOTENCE; MALE; NONHUMAN; PENILE BLOOD VESSEL; PENIS ERECTION; POTENCY DISORDER; PRIORITY JOURNAL; REPRODUCTION; REVIEW; SEXUALITY;

AGE FACTORS; AGED; AGED, 80 AND OVER; HUMANS; IMMUNOHISTOCHEMISTRY; IMPOTENCE; MALE; MIDDLE AGED; PENIS; PREVALENCE; PROGNOSIS; RISK FACTORS;

EID: 0037278004     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068181     Document Type: Review

References (109)

1. Kinsey AC, Pomeroy WB, Martin CE: Sexual Behaviour in the Human Male. Philadelphia, Saunders, 1948.
2. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ: Impotence and its medical and psychological correlates: Results of the Massachusetts Male Ageing Study. J Urol 1994;151:54-61.
3. Bortz WM, Wallace DH, Wiley D: Sexual function in 1202 aging males: Differentiating aspects J Gerontol [A] 1999;54:M237-241.
4. Dunn KM, Croft PR, Hackett GJ: Sexual problems: A study of the prevalence and need for health care in the general population. Fam Pract 1998;15:519-524.
5. Aytac IA, Micknilay JB, Krane RJ: The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999;84:50-56.
6. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP: Incidence of erectile dysfunction in men 40 to 69 years old: Longitudinal results from the Massachusetts Male Ageing Study. J Urol 2000;163:460-463.
7. Garban H, Vernet D, Freedman A, Rajfer J, Gonzalez-Cadavid N: Effect of ageing on nitric oxide-mediated penile erection in rats. Am J Physiol 1995;268:H467-475.
8. Nehra A, Goldstein I, Pabby A, Nugent M, Huang Y, Morenas A, Krane RJ, Udelson D, Saenz de Tejada I, Moreland RB: Mechanisms of venous leakage: A prospective clinicopathological correlation of corporeal function and structure. J Urol 1996;156:1320.
9. Burnett AL: Nitric oxide in the penis: Physiology and pathophysiology. J Urol 1997;157:320.
10. Burnett AL, Lowenstein CJ, Bredt DS, Chang TSK, Snyder SH: Nitric oxide: A physiological mediator of penile erection. Science 1992;257:401.
11. Burnett AL, Calvin DC, Chamness SL, Ricker DD, Crone JK, Chang TSK: Characterization of neuronal and endothelial nitric oxide synthase (NOS) isoforms in the penis and urethra of wild type mice and transgenic mice lacking neuronal NOS. J Urol 1995;153:509A, abstr 1124.
12. Bush PA, Gonzalez NE, Ignarro LJ: Biosynthesis of nitric and citrulline from L-arginine by constitutive nitric oxide synthase present in rabbit corpus cavernosum. Biochem Biophys Res Commun 1992;186:808.
13. Leone AM, Wiklund NP, Hokfelt T, Brundin L, Moncada S: Release of nitric oxide by nerve stimulation in the human urogenital tract. Neuroreport 1994;5:783.
14. Alm P, Larsson B, Ekblad E, Sundler F, Andersson KE: Immunohistochemical localization of peripheral nitric oxide synthase-containing nerves using antibodies raised against synthesized C- and N-terminal fragments of a cloned enzyme from rat brain. Acta Physiol Scand 1993;148:421.
15. Vizzard MA, Erdman SL, Forstermann U, de Groat WC: Differential distribution of nitric oxide synthase in neural pathways to the urogenital organs (urethra, penis, urinary bladder) of the rat. Brain Res 1994;646:279.
16. Sheng H, Schmidt HH, Nakane M, Mitchell JA, Pollock JS, Forstermann U, Murad F: Characterization and localization of nitric oxide synthase in non-adrenergic, non-cholinergic nerves from bovine retractor penis muscles. Br J Pharmacol 1992;106:768.
17. Burnett AL, Tillman SL, Chang TS, Epstein JI, Lowenstein CJ, Bredt DS, Snyder SH, Walsh PC: Immunhistochemical localization of nitric oxide synthase in the autonomic innervation of the human penis. J Urol 1993;150:73.
18. Burnett AL, Saito SS, Maguire MP, Yamaguchi H, Chang TS, Hanley DF: Localization of nitric oxide synthase in spinal nuclei innervating pelvic ganglia. J Urol 1995;153:212.
19. Schmidt PS, Gupta S, Daley J, Saenz de Tejada I: Mechanisms of nitric oxide-induced relaxation of rabbit corpus cavernosum smooth muscle. J Urol 1995;53:442A, abstr 855.
20. +-ATPase and human corpus cavernosum smooth muscle contractility. J Urol 1995; 153:442A, abstr 856.
21. Seftel AD, Viola KA, Kasner SE, Ganz MB: Nitric oxide relaxes rabbit corpus cavernosum smooth muscle via a potassium-conductive pathway. Biochem Biophys Res Commun 1996;219:382.
22. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC: Targeted disruption of the neuronal nitric oxide synthase gene. Cell 1993;75:1273.
23. Hung A, Vernet D, Xie Y, Rajavashisth T, Rodriguez JA, Rajfer J, Gonzalez-Cadavid NF: Expression of the inducible nitric oxide synthase in smooth muscle cells from rat penile corpora cavernosa. J Androl 1995;16:469.
24. Moreland RB: Is there a role of hypoxemia in penile fibrosis: A viewpoint presented to the Society for the Study of Impotence. Int J Impot Res 1998;10:113-120.
25. Lerner S, Melman A, Christ GJ: A review of erectile dysfunction: New insights and more questions J Urol 1993;149:1246.
26. 1 in human corpus cavernosum smooth muscle J Urol 1995;153:826-834.
27. Border WA, Ruoslahti E: Transforming growth factor-β in disease: The dark side of tissue repair. J Clin Invest 1992;90:1-7.
28. Border WA, Noble NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 1994; 331:1266-1291.
29. Majack RA: Beta-type transforming growth factor specifies organizational behaviour in vascular smooth muscle cell cultures. J Cell Biol 1987;105:465-471.
30. Moreland RB, Watkins MT, Nehra A, Huang Y-H, Munarriz R, Salimpour P, Goldstein J, Traish AM: Oxygen tension modulates transforming growth factor β1 expression and PGE production in human corpus cavernosum smooth muscle cells. Mol Urol 1998;2:41-47.
31. Massague J, Attisano L, Wrana JL: The TGF-β family and its composite receptors. Trends Cell Biol 1994;4:172-178.
32. Baum BJ, et al: Effect of cyclic AMP on the intracellular degradation of newly synthesized collagen. J Biol Chem 1980;255:2843-2847.
33. 2 on transforming growth factor-β and insulin-induced collagen formation in lung fibroblasts. J Biol Chem 1989;264:16988-16991.
34. Roy AC, Tan SM, Kottegoda SR, Ratnam SS: Ability of human corpus cavernosum to generate prostaglandins and thromboxanes in vitro. IRCS Med Sci 1984;12:608.
35. Daley JT, et al: Prostanoid production in rabbit corpus cavernosum. I. Regulation by oxygen tension. J Urol 1996;155:1482-1487.
36. Border WA, Ruoslahti E: Transforming growth factor-β in disease: The dark side of tissue repair. J Clin Invest 1992;90:1.
37. Sporn MB, Roberts AB: TGF-β: Problems and prospects. Cell Regul 1990;1:875-882.
38. Roberts AB, Sporn MB: In Sporn MB, Roberts AB (eds): The Handbook of Experimental Pharmacology. Peptide Growth Factors and Their Receptors. Heidelberg, Springer, 1989, pp 419-472.
39. Barnard JA, Lyons RM, Moses HL: The cell biology of transforming growth factor β. Biochim Biophys Acta 1990;1032:79-87.
40. Wahl SM, Hunt DA, Wakefield LM, McCartney-Fancis N, Wahl LM, Roberts AB, Sporn MB: Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 1987;84:5788-5792.
41. Gold LI, Lee TC, Reibman R, Cronstien R, Weissmann G: TGF-β selectively induces neutrophil chemotaxis. J Cell Biochem Suppl 1990;14C:294.
42. Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH: Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor β. J Exp Med 1987;165:251-256.
43. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS: Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986;83:4167-4171.
44. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, Sporn MB, Fauci AS: Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986;163:1037-1050.
45. Ristow H-J: BSC-1 growth inhibitor/type β transforming growth factor is a strong inhibitor of thymocyte proliferation. Proc Natl Acad Sci USA 1986;83:5531-5533.
46. Tsunawaki S, Sporn M, Ding A, Nathan C: Deactivation of macrophages by transforming growth factor-β. Nature (Lond) 1988;334:260-262.
47. Hermans WRM, Rensing BJ, Strauss BH, Serruys PW: Prevention of restenosis after percutaneous transluminal coronary angioplasty: The search for a 'magic bullet'. Am Heart J 1991;122:171-187.
48. MacDonald RG, Henderson MA, Hirshfeld JW, Goldberg SH, Bass T, Vetrovec G, Cowley M, Taussig A, et al: Patient-related variables and restenosis after percutaneous transluminal coronary angioplasty: A report from the M-Heart group. Am J Cardiol 1990;66:926-931.
49. Nobuyoshi M, Kimura T, Ohishi H, Horiuchi H, Nosaka H, Hamasaki N, Yokoi H, Kim K: Restenosis after percutaneous transluminal coronary angioplasty: Pathologic observations in 20 patients. J Am Coll Cardiol 1991;17:433-439.
50. Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy MA: Production of transforming growth factor β1 during repair of arterial injury. J Clin Invest 1991;88:904-910.
51. Sarzani R, Brecher P, Chobanian AV: Growth factor expression in aorta of normotensive and hypertensive rats. J Clin Invest 1989;83:1404-1408.
52. Kim N, Vardi Y, Padma-Nathan H, Daley J, Goldstein I, Saenz de Tejada I: Oxygen tension regulates the nitric oxide pathway: physiological role in the penile erection. J Clin Invest 1993;91:437-442.
53. Rengasamy A, Johns RA: Characterization of endothelium-derived relaxing factor/nitric oxide synthase from bovine cerebellum and mechanism of modulation by high and low oxigen tension. J Pharmacol Exp Ther 1991;259:310-316.
54. Lawrence R, Hartmann DJ, Sonenshein GE: Transforming growth factor β1 stimulator type V collagen expression in bovine smooth muscle cells. J Biol Chem 1994;269:9603-9609.
55. Burnett AL, Tillman SL, Chauf TSK, Epstein JI, Lowenstein CJ, Bredt DS, Snyder SH, Walsh PC: Immunohistochemical localization of nitric oxide synthase in the anatomic innervation of the human penis. J Urol 1993;150:73.
56. Garban H, Vernet D, Freedman A, Rajfer J, Gonzalez-Cadavid N: Effect of ageing on nitric oxide-mediated penile erection in rats Am J Physiol 1995;268:H467-475.
57. Zvara P, Sionfi R, Schipper HM, Begin LR, Brock GB: Nitric oxyde mediated erectile activity is a testosterone dependent event: A rat erection model. Int J Impotence 1995;7:209.
58. Rajasekaran M, Mondal D, Agraval K, Chen I, Hellstrom W, Sikka S: Ex vivo expression of nitric oxide synthase isoforms (eNOS/iNOS) and calmodulin in human penile cavernosal cells. J Urol 1998;160:2210-2215.
59. Yildirim MK, Yildirim S, Utkan T, Sarioglu Y, Yalman Y: Effects of castration on adrenergic, cholinergic and non-adrenergic, non-cholinergic response of isolated corpus cavernosum from rabbit. Br J Urol 1997;79:694-670.
60. Shen ZJ, Lu YL, Chen ZD, Chen F, Chen Z: Effects of androgen and ageing on gene expression of vasoactive intestinal polypeptide in rat corpus cavernosum. BJU Int 2000;86:133-137.
61. Azadoi KM, Goldstein I, Siroky MB, Traish AM, Krane RJ, De Tejada IS: Mechanisms of ischemia-induced cavernosal smooth muscle relaxation impairment in rabbit model of vasculogenic erectile dysfunction. J Urol 1998;160:2216-2222.
62. Zhao W, Christ GJ: Endothelin-1 as a putative modulator of erectile dysfunction. II. Calcium mobilization in cultured human corporeal smooth muscle cells. J Urol 1995;154:1571.
63. Saenz de Tejada I, Carson MP, de las Morenas A, Goldstein I, Traish AM: Endothelin: Localization, synthesis, activity and receptor types in human penile corpus cavernosum. Am J Physiol 1991;261:H1078.
64. Lau LC, Adaikan PG, Ratnam SS: Effect of endothelin-1 on the human corpus cavernosum on penile vasculature. Asia Pacific J Pharmacol 1991;6:287-292.
65. Holunquist F, Andersson KE, Hedlund H: Actions of endothelin on isolated corpus cavernosum from rabbit and man. Acta Physiol Scand 1990;139:113-122.
66. Kumazaki T, Fujii T, Kobayashi M, Mitsui Y: Ageing and growth-dependent modulation of endothelin-1 gene expression in human vascular endothelial cells. Exp Cell Res 1994;211:6-11.
67. Kurihara H, Yoshizumi M, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, Kamaoki M, Kato H, Yazaki Y: Transforming growth factor-β stimulates the expression of endothelin in RNA by vascular endothelial cells. Biochem Biophys Res Commun 1989;159:1435-1440.
68. Azadzoi K, Pabby A, Moreland RB, Siroky M, Krane RJ, Goldstein I: Arteriosclerotic vascular disease affects the mechanical properties of the tunica albuginea. J Impotence Res 1996;8:106.
69. Azadzoi KM, Park K, Andry C, Goldstein I, Siroky MB: Relationship between cavernosal ischemia and corporal veno-occlusive dysfunction in an animal model. J Urol 1997;157:1011.
70. Byrne RR, Henry GD, Rao DS, Huyuh TTT, Pipper AM, Annex BH, Hagen PO, Donatucci CF: Vascular endothelial growth factor restores corporeal smooth muscle function in vitro. J Urol 2001;165:1310.
71. Becker AJ, Lickert S, Stief ChG, Scheller F, Knapp WH, Hartmann U, Brabant G, Jonas U: Serum levels of human growth hormone during different penile conditions in the cavernous and systemic blood of healthy men and patients with erectile dysfunction. Urology 2002;59:609.
72. Lue TF: Erectile dysfunction. N Engl J Med 2000;342:1803.
73. Zhao W, Christ GJ: Endothelin-I as a putative modulator of erectile dysfunction. II. Calcium mobilization in cultured human corporal smooth muscle cells. J Urol 1995;154:1571.
74. Zertich MJ, Khawand NY, Vidic B: Clinical significance of ultrastructural findings in the corpora cavernosa of normal and impotent men. J Urol 1990;143:289.
75. Feron O, Michel JB, Sase K, Michel T: Dynamic regulation of endothelial nitric oxide synthase: Complementary roles of dual acylation and caveolin interactions. Biochemistry 1998;37:193.
76. Bakircioglu ME, Sivert KD, Nunes L, Lan A, Lin CS, Lue TF: Decreased trabecular smooth muscle and caveolin-1 expression in the penile tissue of aged rats. J Urol 2001;166:734.
77. Lin CS, Liu X, Chow S, Lue TF: Cyclic AMP and cyclic GMP activate protein kinase G in cavernosal smooth muscle cells: Old age is a negative factor. BJU International 2002;89:576.
78. Hale TM, Okabe H, Heaton JPW, Adams MA: Antihypertensive drugs induce structural remodeling of the penile vasculature J Urol 2001;166:739.
79. Fogari R, Zoppi A, Poletti L, Marasi G, Mugellini A, Corradi L: Sexual activity in hypertensive men treated with Valsartan or Carvedilol: A crossover study. Am J Hypertens 2001:14:27.
80. Van der Zee R, Murohara T, Luo Z, Zollmann F, Passeri J, Lekutat C, Jsner JM: Vascular endothelial growth factor, vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 1997;95:1030.
81. Hoad JD, Meininger CJ, Ziche M, Granger HJ: VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol 1998;274:H1054.
82. Stanarius A, Ueckert S, Machtens SA, Stief ChG, Wolf G, Jonas U: Immunocytochemical distribution of nitric oxide synthase in the human corpus cavernosum: An electron microscopical study using the tryramide signal amplification technique. Urol Res 2001;29:168.
83. Becker AJ, Ueckert AS, Stief ChG, Scheller F, Knapp WH, Hartmann U, Brabant G, Jonas H: Serum levels of human growth hormone during different penile conditions in the cavernous and systemic blood of healthy men and patients with erectile dysfunction. Urology 2002;59:609.
84. Lee MC, El-Sakka AI, Graziottin TM, Ho HC, Lin CS, Lue TF: The effect of vascular endothelial growth factor on a rat model of traumatic arteriogenic erectile dysfunction. J Urol 2002;167:761.
85. Azadori KM, Saenz de Tejada I: Hypercholesterinemia impairs endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. J Urol 1991;146:238.
86. Krane RJ, Goldstein I, de Tejada IS: Impotence. N Engl J Med 1990;321:1648.
87. Kim J, Klyachkin ML, Svendsen E, Davis MG, Hagen PO, Carson CC: Experimental hypercholesterolemia in rabbits induces cavernosal atherosclerosis with endothelial and smooth muscle cell dysfunction. J Urol 1994;151:198-205.
88. J̈nemann KP, Antenanger J, Konrad T, Pill J, Berle B, Persson-Jünemann C, Alken P: The effect of impaired liquid metabolism on the smooth muscle cells of rabbits. Urol Res 1991;19:271-275.
89. Arendt RM, Wilbut-Lamper U, Hencke L: Increased plasma endothelin patients with hyperlipoproteinemia and stable or instable angina. Circulation 1990;82:4.
90. Sullivan ME, Dashwood MR, Thompson CS, Mikhailidis DP, Morgan RJ: Down-regulation of endothelin-B receptor sites in cavernosal tissue of hypercholesterolaemic rabbit. Br J Urol 1998;81:128.
91. Smith AD: Causes and classification of impotence. Urol Clins N Am 1981;8:79.
92. Zemel P: Sexual dysfunction in the diabetic patient with hypertension. Am J Cardiol 1988;61:27H.
93. Whitehead ED, Klyde BJ: Diabetes-related impotence in the elderly. Clin Geriatr Med 1990;6:771.
94. Grewe R, Lincoln J, Blacklay PF, Pryor JP, Lumely JSP, Bernstock G: Vasoactive intestinal polypeptide-like immunoreactive nerves in diabetic penis. Diabetes 1983;32:1075.
95. Haberman J, Valcic M, Christ G, Melman A: Vasoactive intestinal polypeptide and norepinephrine concentration in the corpora cavernosa of impotent men. Int J Impotence Res 1991;3:21.
96. Sullivan ME, Dashwood MR, Thompson CS, Muddle JR, Mikhailidis DP, Morgan RJ: Alterations in endothelin B receptor sites in cavernosal tissue of diabetic rabbits: Potential relevance to the pathogenesis of erectile dysfunction. J Urol 1997;158:1966.
97. Burckhardt T, Burckhardt M, Karden J, Buttyan R, Shabsigh A, de la Taille A, Ng PY, Anastasiadis AG, Shabsigh R: Reduction of endothelial and smooth muscle density in the corpora cavernosa of the streptozotocin induced diabetic rat. J Urol 2000;164:1807.
98. dp (type II) rats with erectile dysfunction. Endocrinology 1995;136:5709.
99. Podlasek CA, Zelner DJ, Bervig TR, Gonzalez CM, McKenna KE, McVary KT: Characterization and localization of nitric oxide synthase isoforms in the BB/WOR diabetic rat. J Urol 2001;166:746.
100. 1 and endothelin receptor subtypes in normal and diabetic rat corpus cavernosum. Br J Urol 1995;76:203.
101. Haas CA, Seftl AD, Razmjonel K, Ganz MB, Lampel N, Ferguson K: Erectile dysfunction in aging: Upregulation of endothelial nitric oxide synthase. Urology 1998;51:516.
102. Cartledge JJ, Eardley I, Morrison JFB: Nitric oxide-mediated corpus cavernosal smooth muscle relaxation is impaired in ageing and diabetes. BJU Int 2001;87:194.
103. Cartledge JJ, Eardley I, Morrison JFB: Advanced glycation endproducts are responsible for the impairment of corpus cavernosal smooth muscle relaxation in diabetes. BJU Int 2001;87:402.
104. de Tejada JS, Goldstein I, Azadori K, Krane RJ, Cohen RA: Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989;320:1025.
105. Blanco R, de Tejada IS, Goldstein I, Krane RJ, Wotiz HH, Cohen RA: Dysfunctional penile cholinergic nerves in diabetic impotent men. J Urol 1990;144:278.
106. Burnett AL: Nitric oxide in the penis: Physiology and pathology. J Urol 1997;157:320.
107. Colakoglu Z, Kuthnay E, Ertekin C, Altay B, Killi R, Alkis A: Autonomic nerve involvement and venous leakage in diabetic men with impotence BJU Int 1999;83:453.
108. Antieri MV, Melman A, Christ GJ: Identification of a down-regulated mRNA transcript in corpus cavernosum from diabetic patients with erectile dysfunction. Int J Impot Res 1996;8:69.
109. Morley JE: Testosterone replacement and the physiologic aspects of aging in men. Mayo Clin Proc 2000;75(suppl):83-87.